EASL INTERNATIONAL CONSENSUS CONFERENCE ON HEPATITIS B

This publication has 113 references indexed in Scilit:

• Tenofovir Disoproxil Fumarate Therapy for Chronic Hepatitis B in Human Immunodeficiency Virus/Hepatitis B Virus–Coinfected Individuals for Whom Interferon‐α and Lamivudine Therapy Have Failed
  The Journal of Infectious Diseases, 2002
• HBV genotype B is associated with better response to interferon therapy in HBeAg( + ) chronic hepatitis than genotype C
  Hepatology, 2002
• Evidence for the efficacy of peginterferon alfa-2a (40 KD) (PEGASYS) in the treatment of HBeAg-positive chronic hepatitis B (CHB) and impact of baseline factors
  Journal of Hepatology, 2002
• Is it safe to stop lamivudine after the emergence of YMDD mutants during lamivudine therapy for chronic hepatitis B?
  Journal of Hepatology, 2002
• Acute liver graft failure due to emergence of lamivudine resistant hepatitis B virus: rapid resolution during treatment with adefovir
  Gut, 2001
• Hepatitis B virus concentrations in serum determined by sensitive quantitative assays in patients with established chronic hepatitis delta virus infection
  Journal of Medical Virology, 2001
• Elimination of New Chronic Hepatitis B Virus Infections: Results of the Alaska Immunization Program
  The Journal of Infectious Diseases, 2000
• Lamivudine as Initial Treatment for Chronic Hepatitis B in the United States
  New England Journal of Medicine, 1999
• Identification and characterization of mutations in hepatitis B virus resistant to lamivudine
  Hepatology, 1998
• Interferon treatment in patients with chronic hepatitis B: A meta-analysis of the published literature
  Journal of Hepatology, 1993